Table 1.
Disease | Involved genes | |
---|---|---|
Hypophosphatemia | Hypophosphatemia rickets | Activating mutation of FGF23 *** |
Inactivating mutation of PHEX *** | ||
Inactivating mutation of DMP 1 *** | ||
Inactivating mutation of ENPP1 *** | ||
Inactivating mutation of Npt2c ** | ||
Activating translocation of Klotho * / ** | ||
With renal lithiasis and/or osteopenia and/or hypercalciuria | Inactivating mutation of Npt2a ** | |
Inactivating mutation of Npt2c ** | ||
Inactivating mutation of NHERF1 | ||
Mac Cune Albright / fibrous dysplasia of bone | Overexpression of FGF23, GNAS *** | |
Tumor-induced osteomalacia | Overexpression of FGF23, MEPE, FGF7 and/or FRP4 *** | |
Epidermal naevus syndrome | FGF-R3 *** | |
Hyperphosphatemia | Familial tumoral calcinosis | Inactivating mutation of FGF23 ** |
Inactivating mutation of Klotho *** | ||
Inactivating mutation of GALNT3 ** |
FGF: fibroblast growth factor
PHEX: phosphate-regulating gene with homologies to endopeptidases on the X chromosome
DMP1: Dentin matrix protein 1
ENPP1 : ecto-nucleotide pyrophosphatase / phosphodiesterase 1
Npt2a: type IIa sodium-phosphate cotransporter (SLC34A1)
Npt2c: type IIc sodium-phosphate cotransporter (SLC34A3)
MEPE: matrix extracellular phosphoglycoprotein
FRP4: frizzled related protein 4
FGF-R3: fibroblast growth factor receptor 3
GALNT3: UDP-N-acetyl-a-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3
with associated hyperparathyroidism
disease associated with a low FGF23 serum level
disease associated with a high FGF23 serum level